DiaSorin (OTCMKTS:DSRLF) Shares Gap Up – Here’s What Happened

Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF) gapped up before the market opened on Friday. The stock had previously closed at $84.00, but opened at $88.21. DiaSorin shares last traded at $88.21, with a volume of 2 shares trading hands.

Analyst Ratings Changes

DSRLF has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of DiaSorin in a report on Tuesday, August 4th. BNP Paribas Exane cut shares of DiaSorin from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 7th. Zacks Research upgraded shares of DiaSorin from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Finally, UBS Group lowered shares of DiaSorin from a “hold” rating to a “sell” rating in a report on Wednesday, August 12th. Two equities research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Strong Sell”.

DiaSorin Stock Performance

The firm’s 50-day simple moving average is $85.53 and its two-hundred day simple moving average is $78.30.

About DiaSorin

DiaSorin S.p.A. is an Italian healthcare company that develops, manufactures and markets in vitro diagnostic products. Its portfolio is focused on immunodiagnostics and molecular diagnostics used to support the detection and monitoring of diseases and medical conditions.

The company offers diagnostic assays, reagents and analytical systems for areas including infectious diseases, endocrinology, oncology, autoimmune disorders, bone and mineral metabolism, cardiovascular conditions and gastrointestinal diseases.